Merck KGaA Closes $3.9B Deal to Acquire SpringWorks

April 28, 2025, 7:20 am more...

In a major strategic move for its healthcare portfolio, Merck KGaA has locked in a $3.9 billion acquisition of SpringWorks Therapeutics. The deal is aimed at bolstering its cancer treatment capabilities and accelerating future innovation, marking a significant industry shake-up.

pulse2.com / Merck KGaA Buying SpringWorks In $3.9 Billion Deal

techinasia.com / German healthcare firm Merck KGaA to buy SpringWorks for $3.9b

permalink / 2 stories from 2 sources in 8 hours ago #biotech #biotechnology #acquisitions #healthcare #pharmaceuticals +